Neurogene Inc.
USD32.47
+0.19 (+0.59%)
CEO
Rachel L. McMinn
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.04
Prev. Close
$32.28
Day Low
$30.34
Day High
$32.57
52W Low
$14.65
52W High
$37.27
Market Cap
$0.51B
Volume
0.03M
| 7,700 |
| $42.59 |
| 16 Jun 2026 | Woods Keith | director | A-Award | Acquired | 12,050 | $20.40 |
| 16 Jun 2026 | Woods Keith | director: | Disposed | 0 | $0.00 |
| 8 May 2026 | Cvijic Christine Mikail | director, officer: President and CFO | S-Sale | Disposed | 4,800 | $30.07 |
| 8 May 2026 | Cvijic Christine Mikail | director, officer: President and CFO | S-Sale | Disposed | 4,800 | $32.44 |
| 7 May 2026 | Shafer Christina | Chief Commercial Officer | A-Award | Acquired | 120,000 | $28.94 |
| 20 Apr 2026 | Shafer Christina | officer | Disposed | 0 | $0.00 |
| 30 Mar 2026 | Cvijic Christine Mikail | President and CFO | S-Sale | Disposed | 2,558 | $21.62 |
| 30 Mar 2026 | McMinn Rachel | director, officer: Chief Executive Officer | S-Sale | Disposed | 3,352 | $22.07 |